Selected research
Industry Research
Candesartan and Hydrochlorothiazide Industry Research Report 2026
Market perspective
The global Candesartan and Hydrochlorothiazide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Candesartan and Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Candesartan and Hydrochlorothiazide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Candesartan and Hydrochlorothiazide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Candesartan and Hydrochlorothiazide include ANI Pharmaceuticals, Dr. Reddy's Laboratories, MACLEODS, Prinston Pharmaceutical, Zydus Pharmaceuticals, AstraZeneca, Mylan and TEVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Candesartan and Hydrochlorothiazide market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Candesartan and Hydrochlorothiazide Market by Company
ANI Pharmaceuticals
Dr. Reddy's Laboratories
MACLEODS
Prinston Pharmaceutical
Zydus Pharmaceuticals
AstraZeneca
Mylan
TEVA
Candesartan and Hydrochlorothiazide Segment by Type
16/12.5
32/12.5
32/25
Candesartan and Hydrochlorothiazide Segment by Application
Adults
Geriatric
Candesartan and Hydrochlorothiazide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candesartan and Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Candesartan and Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candesartan and Hydrochlorothiazide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Candesartan and Hydrochlorothiazide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Candesartan and Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 16/12.5
- 32/12.5
- 32/25
Applications
- Adults
- Geriatric
Companies covered
- ANI Pharmaceuticals
- Dr. Reddy's Laboratories
- MACLEODS
- Prinston Pharmaceutical
- Zydus Pharmaceuticals
- AstraZeneca
- Mylan
- TEVA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Candesartan and Hydrochlorothiazide Market Size (2021-2032)
- 2.2.2 Global Candesartan and Hydrochlorothiazide Sales (2021-2032)
- 2.2.3 Global Candesartan and Hydrochlorothiazide Market Average Price (2021-2032)
- 2.3 Candesartan and Hydrochlorothiazide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 16/12.5
- 2.3.3 32/12.5
- 2.3.4 32/25
- 2.4 Candesartan and Hydrochlorothiazide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Geriatric
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Candesartan and Hydrochlorothiazide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Candesartan and Hydrochlorothiazide Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Candesartan and Hydrochlorothiazide Revenue of Manufacturers (2021-2026)
- 3.4 Global Candesartan and Hydrochlorothiazide Average Price by Manufacturers (2021-2026)
- 3.5 Global Candesartan and Hydrochlorothiazide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Candesartan and Hydrochlorothiazide, Product Type & Application
- 3.8 Global Manufacturers of Candesartan and Hydrochlorothiazide, Established Date
- 3.9 Global Candesartan and Hydrochlorothiazide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ANI Pharmaceuticals
- 4.1.1 ANI Pharmaceuticals Company Information
- 4.1.2 ANI Pharmaceuticals Business Overview
- 4.1.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
- 4.1.5 ANI Pharmaceuticals Recent Developments
- 4.2 Dr. Reddy's Laboratories
- 4.2.1 Dr. Reddy's Laboratories Company Information
- 4.2.2 Dr. Reddy's Laboratories Business Overview
- 4.2.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolio
- 4.2.5 Dr. Reddy's Laboratories Recent Developments
- 4.3 MACLEODS
- 4.3.1 MACLEODS Company Information
- 4.3.2 MACLEODS Business Overview
- 4.3.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 MACLEODS Candesartan and Hydrochlorothiazide Product Portfolio
- 4.3.5 MACLEODS Recent Developments
- 4.4 Prinston Pharmaceutical
- 4.4.1 Prinston Pharmaceutical Company Information
- 4.4.2 Prinston Pharmaceutical Business Overview
- 4.4.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolio
- 4.4.5 Prinston Pharmaceutical Recent Developments
- 4.5 Zydus Pharmaceuticals
- 4.5.1 Zydus Pharmaceuticals Company Information
- 4.5.2 Zydus Pharmaceuticals Business Overview
- 4.5.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
- 4.5.5 Zydus Pharmaceuticals Recent Developments
- 4.6 AstraZeneca
- 4.6.1 AstraZeneca Company Information
- 4.6.2 AstraZeneca Business Overview
- 4.6.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolio
- 4.6.5 AstraZeneca Recent Developments
- 4.7 Mylan
- 4.7.1 Mylan Company Information
- 4.7.2 Mylan Business Overview
- 4.7.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mylan Candesartan and Hydrochlorothiazide Product Portfolio
- 4.7.5 Mylan Recent Developments
- 4.8 TEVA
- 4.8.1 TEVA Company Information
- 4.8.2 TEVA Business Overview
- 4.8.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 TEVA Candesartan and Hydrochlorothiazide Product Portfolio
- 4.8.5 TEVA Recent Developments
5 Global Candesartan and Hydrochlorothiazide Market Scenario by Region
- 5.1 Global Candesartan and Hydrochlorothiazide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Candesartan and Hydrochlorothiazide Sales by Region: 2021-2032
- 5.2.1 Global Candesartan and Hydrochlorothiazide Sales by Region: 2021-2026
- 5.2.2 Global Candesartan and Hydrochlorothiazide Sales by Region: 2027-2032
- 5.3 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2021-2032
- 5.3.1 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2021-2026
- 5.3.2 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2027-2032
- 5.4 North America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
- 5.4.1 North America Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Candesartan and Hydrochlorothiazide Sales by Country (2021-2032)
- 5.4.3 North America Candesartan and Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
- 5.5.1 Europe Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Candesartan and Hydrochlorothiazide Sales by Country (2021-2032)
- 5.5.3 Europe Candesartan and Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Candesartan and Hydrochlorothiazide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
- 5.7.1 South America Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Candesartan and Hydrochlorothiazide Sales by Country (2021-2032)
- 5.7.3 South America Candesartan and Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2021-2032)
- 6.1.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2021-2032)
- 6.2 Global Candesartan and Hydrochlorothiazide Revenue by Type (2021-2032)
- 6.2.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2021-2032)
- 6.3 Global Candesartan and Hydrochlorothiazide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2021-2032)
- 7.1.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2021-2032)
- 7.2 Global Candesartan and Hydrochlorothiazide Revenue by Application (2021-2032)
- 7.2.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2021-2032)
- 7.3 Global Candesartan and Hydrochlorothiazide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Candesartan and Hydrochlorothiazide Value Chain Analysis
- 8.1.1 Candesartan and Hydrochlorothiazide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Candesartan and Hydrochlorothiazide Production Mode & Process
- 8.2 Candesartan and Hydrochlorothiazide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Candesartan and Hydrochlorothiazide Distributors
- 8.2.3 Candesartan and Hydrochlorothiazide Customers
9 Global Candesartan and Hydrochlorothiazide Analyzing Market Dynamics
- 9.1 Candesartan and Hydrochlorothiazide Industry Trends
- 9.2 Candesartan and Hydrochlorothiazide Industry Drivers
- 9.3 Candesartan and Hydrochlorothiazide Industry Opportunities and Challenges
- 9.4 Candesartan and Hydrochlorothiazide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst